Condition: Relapsing Multiple Sclerosis · Sponsor: Novartis Pharmaceuticals
This is an observational, non-interventional, multicenter, open-label study in patients being treated with any approved injectable or selected oral DMT for RMS in Germany. Prospective, primary data will be collected via questionnaires and an electronic case report form (eCRF) over a period of up to four years. Additionally, medical history of participants will be collected including disease duration, laboratory values, EDSS, MRI parameters and relapses.
This description comes directly from the study's public registry record.
Novartis Pharmaceuticals · +41613241111 · novartis.email@novartis.com
Novartis Pharmaceuticals
Always discuss trial participation with your own doctor first.
| Novartis Investigative Site | Albstadt, Baden-Wurttemberg, Germany | Recruiting |
| Novartis Investigative Site | Hettingen, Baden-Wurttemberg, Germany | Completed |
| Novartis Investigative Site | Hettingen, Baden-Wurttemberg, Germany | Recruiting |
| Novartis Investigative Site | Mannheim, Baden-Wurttemberg, Germany | Recruiting |
| Novartis Investigative Site | Nagold, Baden-Wurttemberg, Germany | Recruiting |
| Novartis Investigative Site | Schwäbisch Hall, Baden-Wurttemberg, Germany | Recruiting |
| Novartis Investigative Site | Schwetzingen, Baden-Wurttemberg, Germany | Recruiting |
| Novartis Investigative Site | Bamberg, Bavaria, Germany | Active Not Recruiting |
| Novartis Investigative Site | Dillingen an der Donau, Bavaria, Germany | Active Not Recruiting |
| Novartis Investigative Site | Munich, Bavaria, Germany | Withdrawn |
| Novartis Investigative Site | Munich, Bavaria, Germany | Withdrawn |
| Novartis Investigative Site | Neuburg A.d. Donau, Bavaria, Germany | Active Not Recruiting |
+ 126 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05344469